Foley Hoag Represents Alloy Therapeutics in $75M Series C Financing
April 12, 2021
Foley Hoag LLP represented biotechnology ecosystem company Alloy Therapeutics in a $75 million Series C Financing. Proceeds from the Series C financing will support the extension of Alloy’s platforms and services into adjacent biologic modalities and further expand access to Alloy’s capabilities to more partners and geographies around the world. The round was led by 8VC, Presight Capital and Peter Thiel, with participation from new investors including Mubadala Capital, an unnamed sovereign wealth fund, Founders Fund and Gaingels, as well as existing investors Luma Bio-IT, Alexandria Venture Investments and Ulysses Diversified Holdings.
Headquartered in Boston, MA, with European labs in Cambridge, UK, Alloy is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, Alloy democratizes access to tools, technologies, services and company creation capabilities that are foundational for discovering and developing therapeutic biologics. The company’s lead offering, the ATX-Gx™ platform, is a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains.
Foley Hoag attorneys Patrick Connolly, Kevin Lin, Mark Potash and Sarah Ropiak represented Alloy in the transaction, with support at key intervals from Earl Mellott, Chasse Osborn, Luciano Racco and Austin Ownbey.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.